Siess M, Bumm R, Molls M, Peschel C, Siewert J R
Klinikum rechts der Isar, Technische Universität München, Ismaningerstrasse 22, 81675 München.
Kongressbd Dtsch Ges Chir Kongr. 2001;118:181-2.
The increasing use of multimodal therapies confronts clinics with the need to create new organisational structures. The high degree of specialisation necessitates that the separate disciplines seek ways of working closer together. This is particularly the case when staging results have to be evaluated and a multimodal therapy course chosen or when quality management issues and the coordination of different steps of a treatment are being considered. By establishing disease-oriented organisational structures and by institutionalizing interdisciplinary cooperation, e.g. in daily tumor board meetings and in fixed disease management teams, the organisational prerequisites for implementing multimodal therapies are created.